Additionally, the upregulation of lncRNA PAR5 resulted in its binding to EZH2 and the inhibition of cell proliferation, invasion, and migration in U87 and U251 human glioma cells; notably, PAR5 expression is positively related to prognosis in glioma patients [59]. This evidence concerns the gene EZH2 and central nervous system cancer.